» Authors » Andrzej C Skladanowski

Andrzej C Skladanowski

Explore the profile of Andrzej C Skladanowski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 347
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kitowska K, Gorska-Arcisz M, Antoun D, Zarczynska I, Czaplinska D, Szczepaniak A, et al.
Front Oncol . 2021 Apr; 11:633410. PMID: 33898310
Deregulation of fibroblast growth factor receptors (FGFRs) signaling, as a result of amplification, chromosomal translocation, or mutations, is involved in both initiation and progression of a wide range of human...
2.
Kitowska K, Kowalska A, Mieszkowska M, Piasecka D, Skladanowski A, Romanska H, et al.
Oncol Lett . 2018 Feb; 15(2):1817-1822. PMID: 29434878
Breast cancer (BCa) is the most common cancer affecting women worldwide. Overexpression of human epidermal growth factor receptor 2 (HER2) occurs in ~20-25% of invasive ductal breast carcinomas and is...
3.
Turczyk L, Kitowska K, Mieszkowska M, Mieczkowski K, Czaplinska D, Piasecka D, et al.
Neoplasia . 2017 Sep; 19(10):791-804. PMID: 28869838
Signaling mediated by growth factors receptors has long been suggested as one of the key factors responsible for failure of endocrine treatment in breast cancer (BCa). Herein we present that...
4.
Grudowska A, Czaplinska D, Polom W, Matuszewski M, Sadej R, Skladanowski A
Acta Biochim Pol . 2017 Mar; 64(1):135-141. PMID: 28291843
Invasion and migration of cancer cells are crucial for the formation of secondary lesions. These require activation of signalling cascades modulated by the number of regulatory molecules. One such molecule...
5.
Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, et al.
Oncotarget . 2016 Nov; 7(52):86011-86025. PMID: 27852068
We have recently demonstrated that, fibroblast growth factor 2 (FGFR2), signalling via ribosomal S6 kinase 2 (RSK2), promotes progression of breast cancer (BCa). Loss of progesterone receptor (PR), whose activity...
6.
Czaplinska D, Mieczkowski K, Supernat A, Skladanowski A, Kordek R, Biernat W, et al.
Tumour Biol . 2016 Aug; 37(10):13721-13731. PMID: 27476168
We have previously demonstrated that fibroblast growth factor receptor 2 (FGFR2) activates ribosomal s6 kinase 2 (RSK2) in mammary epithelial cells and that this pathway promotes in vitro cell growth...
7.
Koszalka P, Golunska M, Urban A, Stasilojc G, Stanislawowski M, Majewski M, et al.
PLoS One . 2016 Mar; 11(3):e0151420. PMID: 26964090
CD73 (ecto-5'-nucleotidase), a cell surface enzyme hydrolyzing AMP to adenosine, was lately demonstrated to play a direct role in tumor progression including regulation of tumor vascularization. It was also shown...
8.
Piasecka D, Skladanowski A, Kordek R, Romanska H, Sadej R
Postepy Biochem . 2015 Dec; 61(2):198-206. PMID: 26689013
Progesterone receptor (PR) and its specific ligand play a key role in development and physiology of mammary gland. The role of PR in initiation and progression of breast carcinoma (BCa)...
9.
Koszalka P, Golunska M, Stanislawowski M, Urban A, Stasilojc G, Majewski M, et al.
Int J Biochem Cell Biol . 2015 Nov; 69:1-10. PMID: 26545615
Ecto-5'-nucleotidase (CD73), an enzyme providing interstitial adenosine, mediates diverse physiological and pathological responses. In tumor progression, it has primarily an immunosuppressive role but is also thought to regulate neovascularization. However,...
10.
Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska A, Skladanowski A, et al.
Biochim Biophys Acta . 2014 Jul; 1843(11):2461-70. PMID: 25014166
The members of p90 ribosomal S6 kinase (RSK) family of Ser/Thr kinases are downstream effectors of MAPK/ERK pathway that regulate diverse cellular processes including cell growth, proliferation and survival. In...